Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the information related to Cabozantinib in patients with advanced Penile Squamous Cell Carcinoma (PSCC) in the clinical trial study.
    Difference
    0.0%
    Check dated 2024-06-06T14:23:01.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying inclusion and exclusion criteria such as age, health conditions, and prior treatments. Previously, this section only indicated that no information was provided.
    Difference
    18%
    Check dated 2024-05-22T19:54:15.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T22:27:48.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.